— Know what they know.
Not Investment Advice

DXR NASDAQ

Daxor Corporation
1W: -3.6% 1M: -1.2% 3M: +0.8% YTD: -26.1% 1Y: -21.9% 3Y: +6.3% 5Y: +8.4%
$10.62
-0.36 (-3.28%)
 
Weekly Expected Move ±7.3%
$9 $10 $11 $11 $12
NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Neutral · Power 53 · $62.0M mcap · 3M float · 0.495% daily turnover · Short 53% of daily vol
Smart Money Score
Bullish 75
Insider+$0.0M
Congress—
ETF Holdings—
Key Statistics
Market Cap$62.0M
52W Range8.56-14.76
Volume8,294
Avg Volume12,414
Beta0.26
Dividend—
Analyst Ratings
3 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOMichael Richard Feldschuh
Employees37
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date1983-07-25
Websitedaxor.com
109 Meco Lane
Oak Ridge, TN 37830
US
12123308500
About Daxor Corporation

Based in Oak Ridge, Tennessee, Daxor Corporation is a medical technology enterprise founded in 1971. The company specializes in blood volume measurement, developing and commercializing the BVA-100 Blood Volume Analyzer. This diagnostic instrument offers a precise, objective method for quantifying a patient's blood volume status and composition, comparing these metrics against their unique physiological norms. It is utilized across a wide spectrum of medical and surgical contexts. Prior to May 1973, the organization operated under the name Idant Corporation.

Recent Insider Trades

NameTypeSharesPriceDate
Jefferies John A-Award 2,451 — 2026-08-28
Michel Robert J A-Award 12,000 — 2026-06-23
Feldschuh Michael Ri A-Award 30,000 — 2026-06-23
Feldschuh Jonathan A A-Award 25,000 — 2026-06-23
Goudie Joy S. A-Award 2,500 $10.14 2026-06-23

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms